171 related articles for article (PubMed ID: 6987848)
1. Sensitivity of normal and neoplastic cells to chemotherapeutic agents in vitro.
Dow LW
Adv Intern Med; 1980; 25():427-52. PubMed ID: 6987848
[No Abstract] [Full Text] [Related]
2. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
Laerum OD
Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
[No Abstract] [Full Text] [Related]
3. The role of cell kinetics in cancer chemotherapy.
Valeriote FA; Edelstein MB
Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
[No Abstract] [Full Text] [Related]
4. [Cyclic purine nucleotides, 3',5'-AMP and 3',5'-GMP, as factors regulating the proliferation and differentiation of hemopoeitic cells].
Fedorov NA
Usp Sovrem Biol; 1975; 79(2):225-40. PubMed ID: 169644
[No Abstract] [Full Text] [Related]
5. Cell division and disseminated neoplastic disease in man: a review.
Wagner HP; Burgener F
Aktuelle Probl Chir; 1970; 14():113-59. PubMed ID: 4146416
[No Abstract] [Full Text] [Related]
6. [Treatment of neoplasms of the hematopoietic system based on some principles of cytokinetics].
Traczyk Z
Acta Haematol Pol; 1974; 5(1):85-90. PubMed ID: 4595062
[No Abstract] [Full Text] [Related]
7. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
Cashman JD; Eaves AC; Wolpe S; Eaves CJ
Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
[No Abstract] [Full Text] [Related]
8. Properties of antileukaemic drugs.
Brusamolino E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
[No Abstract] [Full Text] [Related]
9. Differential effects of cytotoxic agents on hematopoietic progenitors.
Botnick LE; Hannon EC; Vigneulle R; Hellman S
Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
[TBL] [Abstract][Full Text] [Related]
10. Functional organization of the hematopoietic stem cell compartment: implications for cancer and its therapy.
Hellman S; Reincke U; Botnick L; Mauch P
J Clin Oncol; 1983 Apr; 1(4):277-84. PubMed ID: 6366136
[TBL] [Abstract][Full Text] [Related]
11. Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.
Berger MG; Berger J; Richard C; Jeanpierre S; Nicolini FE; Tournilhac O; Michallet M; Maguer-Satta V
Leukemia; 2008 Nov; 22(11):2131-4. PubMed ID: 18596744
[No Abstract] [Full Text] [Related]
12. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
[TBL] [Abstract][Full Text] [Related]
13. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
14. Methionine dependency of cell growth in normal and malignant hematopoietic cells.
Kano Y; Sakamoto S; Kasahara T; Kusumoto K; Hida K; Suda K; Ozawa K; Miura Y; Takaku F
Cancer Res; 1982 Aug; 42(8):3090-2. PubMed ID: 6980046
[TBL] [Abstract][Full Text] [Related]
15. Effect of interferon on erythropoietic differentiation.
Rossi GB; Dolei A; Cioè L; Peschle C
Tex Rep Biol Med; 1981-1982; 41():381-7. PubMed ID: 6184829
[No Abstract] [Full Text] [Related]
16. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
Douay L; Giarratana MC; Labopin M; Bardinet D; Bouchet S; Gorin NC
Bone Marrow Transplant; 1995 May; 15(5):769-75. PubMed ID: 7670404
[TBL] [Abstract][Full Text] [Related]
17. Drugs and the bone marrow.
Treleaven J; Barrett J
Br J Hosp Med; 1990 Oct; 44(4):245-50. PubMed ID: 2249099
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo assessment of the viability of cryopreserved postmortem murine bone marrow cells.
Liu PI; Poon KC; Hong CC; Crook L; Liu SS; Eguchi M
Ann Clin Lab Sci; 1980; 10(2):165-8. PubMed ID: 7387123
[TBL] [Abstract][Full Text] [Related]
19. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
20. [The role of SC-1(+)- and Thy-1(+)-cells in the regulation of cytokine production by cells of the bone marrow regenerating after cytostatic action].
Dygaĭ AM; Sherstoboev EIu; Gol'dberg ED
Biull Eksp Biol Med; 1998 Apr; 125(4):374-7. PubMed ID: 9631712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
